Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TachoSil in Prostate and Bladder Cancer PLND
NCT02001857Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Sep 2013
- Primary completion
- Feb 2017
- Countries
- 1
01
Overview
A Phase 4 trial of tachosil in prostate cancer (PCa), bladder cancer, sponsored by Ghent University Hospital. Started Sep 2013; status: completed.
02
Drugs
tachosil
03
Conditions
prostate cancer (PCa)bladder cancer
Beyond the preview
Go deeper on NCT02001857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02001857.